Figure 1. MOS attenuates disease activity in mice during dextran sulphate sodium (DSS)- induced colitis.

Mean ± SEM values for body weight gain during 8 days’ treatment (A) and daily food intake (B). At autopsy the colon weight/length ratio was calculated (C), mucosa thickness (D) was measured on histological sections. **p < 0.01 and *p < 0.05 compared to control mice; ⁺⁺p < 0.01 and p < 0.05 compared to DSS-treated animals.